Trius Therapeutics, 6310 Nancy Ridge Dr., San Diego, CA 92121, USA.
Bioorg Med Chem Lett. 2013 Mar 1;23(5):1529-36. doi: 10.1016/j.bmcl.2012.11.032. Epub 2012 Dec 5.
The bacterial topoisomerases DNA gyrase (GyrB) and topoisomerase IV (ParE) are essential enzymes that control the topological state of DNA during replication. The high degree of conservation in the ATP-binding pockets of these enzymes make them appealing targets for broad-spectrum inhibitor development. A pyrrolopyrimidine scaffold was identified from a pharmacophore-based fragment screen with optimization potential. Structural characterization of inhibitor complexes conducted using selected GyrB/ParE orthologs aided in the identification of important steric, dynamic and compositional differences in the ATP-binding pockets of the targets, enabling the design of highly potent pyrrolopyrimidine inhibitors with broad enzymatic spectrum and dual targeting activity.
细菌拓扑异构酶 DNA 回旋酶(GyrB)和拓扑异构酶 IV(ParE)是在复制过程中控制 DNA 拓扑状态的必需酶。这些酶的 ATP 结合口袋高度保守,这使得它们成为广谱抑制剂开发的有吸引力的靶标。从基于药效团的片段筛选中鉴定出具有优化潜力的吡咯并嘧啶骨架。使用选定的 GyrB/ParE 同源物进行抑制剂复合物的结构表征有助于确定靶标 ATP 结合口袋中重要的空间、动态和组成差异,从而设计出具有广谱酶谱和双重靶向活性的高效吡咯并嘧啶抑制剂。